Free Trial
→ Market Panic: Trump Just Dropped a Bomb on Your Stocks (From American Alternative) (Ad)tc pixel Free ISRG Stock Alerts

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical logo
$473.30 -0.54 (-0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$472.60 -0.70 (-0.15%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 20 Analyst Ratings
Sell
1
Hold
6
Buy
13

Based on 20 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 1 has given a sell rating, 6 have given a hold rating, and 13 have given a buy rating for ISRG.

Consensus Price Target

$595.95
25.91% Upside
According to the 20 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $595.95. The highest price target for ISRG is $700.00, while the lowest price target for ISRG is $440.00. The average price target represents a forecasted upside of 25.91% from the current price of $473.30.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISRG Analyst Ratings Over Time

TypeCurrent Forecast
8/29/24 to 8/29/25		1 Month Ago
7/30/24 to 7/30/25		3 Months Ago
5/31/24 to 5/31/25		1 Year Ago
8/30/23 to 8/29/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
Hold
6 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$595.95$592.05$596.05$446.45
Forecasted Upside25.91% Upside18.29% Upside8.15% Upside-8.36% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Intuitive Surgical Stock vs. The Competition

TypeIntuitive SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside25.77% Upside15,720.96% Upside10.25% Upside
News Sentiment Rating
Positive News

See Recent ISRG News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/22/2025Deutsche Bank Aktiengesellschaft
2 of 5 stars		 Reiterated RatingSell ➝ Sell
8/20/2025Zacks Research
0 of 5 stars		 DowngradeStrong-Buy ➝ Hold
8/19/2025Royal Bank Of Canada
3 of 5 stars		Shagun Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform ➝ Outperform$615.00+26.99%
7/23/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Danielle Antalffy
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetNeutral ➝ Neutral$547.00 ➝ $585.00+16.55%
7/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Adam Maeder
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$575.00 ➝ $595.00+19.91%
7/23/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Richard Newitter
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$590.00 ➝ $600.00+20.81%
7/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Larry Biegelsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$559.00 ➝ $599.00+18.92%
7/23/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Hold
7/23/2025BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Ryan Zimmerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$566.00 ➝ $571.00+11.74%
7/8/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Vijay Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetIn-Line ➝ In-Line$470.00 ➝ $550.00+2.86%
5/22/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Joanne Wuensch
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy ➝ Buy$590.00 ➝ $650.00+19.27%
4/24/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Matt Miksic
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOverweight ➝ Overweight$684.00 ➝ $635.00+24.97%
4/23/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Rescott
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform ➝ Outperform$600.00 ➝ $575.00+20.11%
1/27/2025CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$550.00-4.17%
1/27/2025Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$490.00 ➝ $548.00-4.43%
1/27/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$475.00 ➝ $575.00+0.30%
1/27/2025Bernstein Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$655.00 ➝ $700.00+22.16%
1/24/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Jayson Bedford
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOutperform ➝ Outperform$560.00 ➝ $688.00+17.20%
1/24/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Robbie Marcus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$575.00 ➝ $675.00+10.90%
12/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$525.00 ➝ $610.00+11.22%
12/2/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeEqual Weight ➝ Overweight$522.00 ➝ $650.00+19.93%
10/18/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Roman
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target$604.00+15.73%
10/18/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMarket Perform ➝ Market Perform
10/17/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Anthony Petrone
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target$440.00 ➝ $500.00+5.30%
8/2/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating		E. Ridley-Day
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeNeutral ➝ Buy$380.00 ➝ $510.00+13.10%
11/17/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$318.00+4.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:07 PM ET.


Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 26, 2025. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

  • The current stock price is around $492, reflecting a strong market position and investor interest in the company's innovative surgical technologies.
  • Intuitive Surgical, Inc. has a solid track record of developing advanced robotic surgical systems, which enhance the quality of minimally invasive procedures, potentially leading to better patient outcomes.
  • Recent insider trading activity indicates confidence in the company's future, with executives actively managing their stock holdings, suggesting they believe in the long-term growth potential.
  • The company has demonstrated consistent revenue growth, driven by increasing adoption of its robotic systems in hospitals and surgical centers worldwide.
  • Intuitive Surgical, Inc. is a leader in the minimally invasive surgery market, which is expected to grow as healthcare providers seek to improve patient recovery times and reduce hospital stays.

Intuitive Surgical
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

  • Recent insider sales, including a significant transaction by an executive vice president, may raise concerns about the company's short-term performance and insider confidence.
  • The stock has experienced fluctuations, which could indicate volatility and uncertainty in the market, potentially affecting investor sentiment.
  • With corporate insiders owning only 0.70% of the company's stock, there may be a lack of alignment between management and shareholder interests.
  • Increased competition in the robotic surgery market could pressure Intuitive Surgical, Inc.'s market share and pricing strategies, impacting future profitability.
  • Regulatory challenges and the need for continuous innovation in surgical technology may pose risks to the company's growth trajectory and operational stability.

ISRG Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $595.95, with a high forecast of $700.00 and a low forecast of $440.00.

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.

According to analysts, Intuitive Surgical's stock has a predicted upside of 25.91% based on their 12-month stock forecasts.

Over the previous 90 days, Intuitive Surgical's stock had 2 downgrades and 1 upgrade by analysts.

Analysts like Intuitive Surgical less than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.60 while the average consensus rating score for "medical" companies is 2.78. Learn more on how ISRG compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NASDAQ:ISRG) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel